Patents by Inventor Mary Ryan

Mary Ryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220348647
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: June 29, 2022
    Publication date: November 3, 2022
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Patent number: 11414484
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: August 16, 2022
    Assignee: Janssen Biotech, Inc.
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Publication number: 20210017267
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Inventors: Ken BOAKYE, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Patent number: 10829549
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: November 10, 2020
    Assignee: Jannsen Biotech, Inc.
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Publication number: 20180171007
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 21, 2018
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Patent number: 9944697
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: April 17, 2018
    Assignee: JANSSON BIOTECH, INC.
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Publication number: 20170024804
    Abstract: Systems and methods for receiving and processing online orders for items and/or services to be fulfilled by the retailer using multiple different fulfillment channels or methods for multiple items in a single order are provided. In certain embodiments, the methods comprise: receiving data regarding a plurality of items selected for purchase from a retailer by a customer in an order, wherein one or more possible fulfillment channels are associated with each of the items; assigning a fulfillment channel for each of the items in the order, wherein at least two different fulfillment channels are assigned within the order; receiving payment information from the customer for the order; and retrieving and/or preparing the items in the order for fulfillment to the customer via at least two different fulfillment channels.
    Type: Application
    Filed: July 23, 2015
    Publication date: January 26, 2017
    Inventors: Paul Steven Tepfenhart, JR., Kedar Dilip Patel, Joshua Frank Morales, William Andrew Chancellor, JR., Tiffany Brooke Doege, Melissa Mary Ryan, Elizabeth Ann Bonilla
  • Patent number: 9481734
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 1, 2016
    Assignee: Janssen Biotech, Inc.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Publication number: 20150125458
    Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: November 6, 2014
    Publication date: May 7, 2015
    Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
  • Patent number: 9012602
    Abstract: Isolated polynucleotides encoding Macaca fascicularis CCL17 (CynoCCL17), polypeptides obtainable from expression of these polynucleotides, recombinant cells, and methods of use are disclosed.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: April 21, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Michael Naso, Mary Ryan, Sandra Santulli-Marotto, Bethany Swencki-Underwood
  • Patent number: 8924334
    Abstract: A system (1) comprises a physical surgical simulator (11) which transmits data concerning physical movement of training devices to an analysis engine (12). The engine (12) automatically generates rules for a rule base (13a) in a learning system (13). The learning system (13) also comprises content objects (13b) and 3D scenario objects (13c). A linked set of a 3D scenario object (13c), a rule base (13a), and a content object (13b) are together a lesson (10). Another simulator (14) is operated by a student. This transmits data concerning physical movement of training devices by a student to a verification engine (15). The verification engine (15) interfaces with the rule base (13a) to display the lesson in the manner defined by the lesson rule base (13a). It calculates performance measures defined in the lesson rule base (13a). It also records the performance measures into a lesson record (18) and it adapts the display of the lesson in line with the parameters defined in the lesson rule base (13a).
    Type: Grant
    Filed: August 12, 2005
    Date of Patent: December 30, 2014
    Assignee: CAE Healthcare Inc.
    Inventors: Gerard Lacey, Donncha Mary Ryan, Derek Cassidy, John Griffin, Laurence Griffin
  • Patent number: 8906649
    Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: December 9, 2014
    Assignee: Janssen Biotech, Inc.
    Inventors: John Kehoe, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler, Jennifer Lee Gardiner
  • Publication number: 20140220634
    Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: February 6, 2013
    Publication date: August 7, 2014
    Applicant: Janssen Biotech, Inc.
    Inventors: John Kehoe, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler, Jennifer Lee Gardiner
  • Publication number: 20130239238
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 12, 2013
    Applicant: JANSSEN BIOTECH INC.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Patent number: 8501907
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: August 6, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Patent number: 8394378
    Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: March 12, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: John Kehoe, Jennifer Lee Gardiner, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler
  • Publication number: 20120108795
    Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: September 26, 2011
    Publication date: May 3, 2012
    Inventors: John Kehoe, Jennifer Lee Gardiner, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler
  • Publication number: 20120082622
    Abstract: Isolated polynucleotides encoding Macaca fascicularis CCL17 (CynoCCL17), polypeptides obtainable from expression of these polynucleotides, recombinant cells, and methods of use are disclosed.
    Type: Application
    Filed: September 26, 2011
    Publication date: April 5, 2012
    Inventors: Michael Naso, Mary Ryan, Sandra Santulli-Marotto, Bethany Swencki-Underwood
  • Patent number: 8146131
    Abstract: A method of producing an audio/video format recording in a venue includes correlating multiple unique viewing position in the venue to viewers. An event is then recorded the venue that viewers are attending. Multiple custom versions of recordings or productions are created corresponding to the viewers. Such custom versions are then made available to corresponding viewers.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: March 27, 2012
    Assignee: The Runway Club
    Inventors: John P. Doffing, Mary Ryan, Scott Emkovik, Paul Volker
  • Publication number: 20100202751
    Abstract: A method of producing an audio/video format recording in a venue includes correlating multiple unique viewing position in the venue to viewers. An event is then recorded the venue that viewers are attending. Multiple custom versions of recordings or productions are created corresponding to the viewers. Such custom versions are then made available to corresponding viewers.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: The Runway Club, Inc.
    Inventors: J. P. Doffing, Mary Ryan, Scott Emkovik, Paul Volker